Company profile
HitGen Inc.
Novel Molecules for Innovative Medicines
- Industry
- Biotechnology Research
- Employees
- 87
- Headquarters
- Chengdu, Sichuan
- Founded
- 2012
- LinkedIn followers
- 8,900
- Office locations
- 1
HitGen Inc. company summary
HitGen Inc. is a company in the Biotechnology Research industry, headquartered in Chengdu, Sichuan, founded in 2012. On LinkedIn the company has around 87 employees and 8,900 followers. Its listed specialties include Hit identification, Lead generation, Chemical library synthesis, Early phase R&D, Protein production and purification.
What technology does HitGen Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About HitGen Inc.
HitGen Inc. (SSE: 688222.SH), is a drug discovery research company headquartered in Chengdu, China, with subsidiaries in Cambridge, UK and Houston, USA. HitGen has established leading technology platforms to enable the discovery and optimization of small molecules and nucleic acid-based drugs. Our key technology platforms include world-leading DNA-encoded library technology (DEL), fragment-based drug discovery and structure-based drug design technologies (FBDD/SBDD), as well as the emerging technology platforms for oligonucleotide-based therapeutics (OBT), and targeted protein degradation technology (TPD). Meanwhile, we are developing a DEL+AI+ Automated DMTA (Design-Make-Test-Analyze) molecular optimization platform to accelerate the discovery and optimization process of preclinical candidate compounds. Through our diverse and flexible business models, we have built up collaboration partnerships with several hundred biopharmaceutical research organizations worldwide. HitGen has multiple programmes from early discovery to clinical trial stage. For more information, please call +86-28-85197385, +1-508-840-9646 or visit www.hitgen.com. For media inquiries: media@hitgen.com For investor inquiries: investors@hitgen.com For business development: bd@hitgen.com
Specialties
Where is HitGen Inc. located?
HitGen Inc. lists 1 location.
Compare companies similar to HitGen Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
HitGen Inc. hitgen.com | Biotechnology Research | 87 | 2012 | Chengdu, Sichuan |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about HitGen Inc.
What does HitGen Inc. do?
HitGen Inc. (SSE: 688222.SH), is a drug discovery research company headquartered in Chengdu, China, with subsidiaries in Cambridge, UK and Houston, USA. HitGen has established leading technology platforms to enable the discovery and optimization of small molecules and nucleic acid-based drugs. Our key technology platforms include world-leading DNA-encoded library technology (DEL), fragment-based drug discovery and structure-based drug design technologies (FBDD/SBDD), as well as the emerging technology platforms for oligonucleotide-based therapeutics (OBT), and targeted protein degradation technology (TPD). Meanwhile, we are developing a DEL+AI+ Automated DMTA (Design-Make-Test-Analyze) molecular optimization platform to accelerate the discovery and optimization process of preclinical candidate compounds. Through our diverse and flexible business models, we have built up collaboration partnerships with several hundred biopharmaceutical research organizations worldwide. HitGen has multiple programmes from early discovery to clinical trial stage. For more information, please call +86-28-85197385, +1-508-840-9646 or visit www.hitgen.com. For media inquiries: media@hitgen.com For investor inquiries: investors@hitgen.com For business development: bd@hitgen.com
How many employees does HitGen Inc. have?
HitGen Inc. has around 87 employees on LinkedIn.
Where is HitGen Inc. headquartered?
HitGen Inc. is headquartered in Chengdu, Sichuan.
When was HitGen Inc. founded?
HitGen Inc. was founded in 2012.
Build a lead list from companies like HitGen Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.